Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of lipid storage diseases and Fabry disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 766.00 | |
50 mg | 6-8 weeks | $ 995.00 | |
100 mg | 6-8 weeks | $ 1,760.00 |
Description | Lucerastat is a very effective and selective α-gal A (α-D-galactosidase) inhibitor for the treatment of lipid storage diseases and Fabry disease. |
Synonyms | NBDGJ |
Molecular Weight | 219.28 |
Formula | C10H21NO4 |
CAS No. | 141206-42-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lucerastat 141206-42-0 NBDGJ inhibitor inhibit